Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

DOI Full Paper Access

299

Citations

23

References

2014

Year

Joyce O’Shaughnessy, Lee Schwartzberg, Michael Danso, Kathy D. Miller, Hope S. Rugo, Marcus A. Neubauer, Nicholas J. Robert, Beth A. Hellerstedt, Mansoor N. Saleh, Paul Richards,

Journal of Clinical Oncology

Abstract

The trial did not meet the prespecified criteria for the coprimary end points of PFS and OS in the ITT population. The potential benefit with iniparib observed in second-/third-line subgroup warrants further evaluation.

References

	Year	Citations

Page 1